Streptozotocin in advanced small cell bronchogenic carcinoma: An ineffective nonmyelosuppressive agent

P. A. Bunn, D. C. Ihde, M. H. Cohen, S. E. Shackney, J. D. Minna

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Thirteen patients with advanced small cell bronchogenic carcinoma (SCBC) received at least three weekly cycles of iv streptozotocin (STZ). There were no objective responses. Four patients progressed by the third week of therapy and an additional eight by the fourth week. Toxicity was acceptable especially in view of the extensive prior therapy. STZ is unlikely to be of benefit in combination chemotherapy regimens for SCBC.

Original languageEnglish (US)
Pages (from-to)479-481
Number of pages3
JournalCancer Treatment Reports
Volume62
Issue number3
StatePublished - 1978

Fingerprint

Small Cell Carcinoma
Bronchogenic Carcinoma
Streptozocin
Combination Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Streptozotocin in advanced small cell bronchogenic carcinoma : An ineffective nonmyelosuppressive agent. / Bunn, P. A.; Ihde, D. C.; Cohen, M. H.; Shackney, S. E.; Minna, J. D.

In: Cancer Treatment Reports, Vol. 62, No. 3, 1978, p. 479-481.

Research output: Contribution to journalArticle

Bunn, P. A. ; Ihde, D. C. ; Cohen, M. H. ; Shackney, S. E. ; Minna, J. D. / Streptozotocin in advanced small cell bronchogenic carcinoma : An ineffective nonmyelosuppressive agent. In: Cancer Treatment Reports. 1978 ; Vol. 62, No. 3. pp. 479-481.
@article{d6fa0caa17cb4f0c882f77f81e583f3d,
title = "Streptozotocin in advanced small cell bronchogenic carcinoma: An ineffective nonmyelosuppressive agent",
abstract = "Thirteen patients with advanced small cell bronchogenic carcinoma (SCBC) received at least three weekly cycles of iv streptozotocin (STZ). There were no objective responses. Four patients progressed by the third week of therapy and an additional eight by the fourth week. Toxicity was acceptable especially in view of the extensive prior therapy. STZ is unlikely to be of benefit in combination chemotherapy regimens for SCBC.",
author = "Bunn, {P. A.} and Ihde, {D. C.} and Cohen, {M. H.} and Shackney, {S. E.} and Minna, {J. D.}",
year = "1978",
language = "English (US)",
volume = "62",
pages = "479--481",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Streptozotocin in advanced small cell bronchogenic carcinoma

T2 - An ineffective nonmyelosuppressive agent

AU - Bunn, P. A.

AU - Ihde, D. C.

AU - Cohen, M. H.

AU - Shackney, S. E.

AU - Minna, J. D.

PY - 1978

Y1 - 1978

N2 - Thirteen patients with advanced small cell bronchogenic carcinoma (SCBC) received at least three weekly cycles of iv streptozotocin (STZ). There were no objective responses. Four patients progressed by the third week of therapy and an additional eight by the fourth week. Toxicity was acceptable especially in view of the extensive prior therapy. STZ is unlikely to be of benefit in combination chemotherapy regimens for SCBC.

AB - Thirteen patients with advanced small cell bronchogenic carcinoma (SCBC) received at least three weekly cycles of iv streptozotocin (STZ). There were no objective responses. Four patients progressed by the third week of therapy and an additional eight by the fourth week. Toxicity was acceptable especially in view of the extensive prior therapy. STZ is unlikely to be of benefit in combination chemotherapy regimens for SCBC.

UR - http://www.scopus.com/inward/record.url?scp=0018185328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018185328&partnerID=8YFLogxK

M3 - Article

C2 - 148321

AN - SCOPUS:0018185328

VL - 62

SP - 479

EP - 481

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -